Pharmacogenomics of Asparaginase Induced Hepatotoxicity
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
Recruiting · NCT03568266 · Registry updated 2026-06-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacogenomics of Asparaginase Induced Hepatotoxicity | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Not stated | 2026-06-01 | NCT03568266 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| University of Southern California | 216 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Los Angeles General Medical Center | Los Angeles | United States | 179 |
| USC / Norris Comprehensive Cancer Center | Los Angeles | United States | 249 |